Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2014 Volume 10 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2014 Volume 10 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro

  • Authors:
    • Wen‑Wei Luo
    • Juan‑Mei Yang
    • Zhao Han
    • Ya‑Sheng Yuan
    • Hai‑Bin Sheng
    • Xiang Liu
    • Fang‑Lu Chi
  • View Affiliations / Copyright

    Affiliations: Department of Otolaryngology‑Head and Neck Surgery, Eye and ENT Hospital of Fudan University, Xuhui, Shanghai 200031, P.R. China
    Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 15-20
    |
    Published online on: April 30, 2014
       https://doi.org/10.3892/mmr.2014.2202
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Atonal homolog 1 (Atoh1) is a basic helix‑loop‑helix transcription factor that is essential for inner ear hair cell differentiation. Previous studies have reported that Atoh1 gene transfer induces the production of ectopic hair cell‑like cells (EHCLCs). In the present study, the effect of different Atoh1 expression levels and the duration of EHCLC formation on the lesser epithelial ridge (LER) of cochleae was examined using a human adenovirus serotype 5 (Ad5) vector encoding atoh1 and the reporter gene EGFP. Different Ad5‑EGFP‑atoh1/Ad5‑EGFP virus titers were added to cultured cochlear explants and EHCLCs were detected in the LER at various time points. The results demonstrated that GFP alone did not induce EHCLCs. By contrast, Atoh1 expression induced EHCLCs as early as 2.5‑5 days following EGFP‑atoh1 infection in the LER and depending upon the viral titer, the number of EHCLCs increased with time. Higher Ad5‑EGFP‑atoh1 titers induced enhanced Atoh1 expression, resulting in an increase in EHCLCs. Lower Ad5‑EGFP‑atoh1 titers required more time for EHCLC formation and very low titers of Ad5‑EGFP‑atoh1 induced only weak Atoh1 expression and did not trigger EHCLC formation. In conclusion, the present study utilized an appropriate Ad5‑EGFP‑atoh1 titer range to induce Atoh1 expression and the subsequent production of EHCLCs. The results revealed that the Atoh1 expression level defined the fate of LER cells as either EHCLCs or nonsensory epithelial cells. This evidence may provide an important guideline for future studies into gene therapy strategies for the treatment of deafness.

Introduction

Hair cells (HCs) transform sound and balance signals into electrical impulses in the cochlear and vestibular end organs. By contrast to vertebrates that are able to spontaneously regenerate new hair and supporting cells (1,2), there is no effective way to stimulate their regeneration in mammals once hair cells have been damaged by noise, ototoxic drugs or aging, which hampers the treatment of sensorin, a neural hearing impairment that is caused by hair cell loss.

Atoh1 is a basic helix-loop-helix transcription factor that is crucial in hair cell formation (3,4). Knockout of atoh1 in mice results in the absence of differentiated hair cells and supporting cells, while Atoh1 overexpression in cultured explants or in vivo induces ectopic hair cell-like cell (EHCLC) formation (3,5–14).

Studies in a novel atoh1 ‘self-terminating’ mouse model have suggested that Atoh1 expression level and duration is crucial for inner and outer hair cell differentiation in vivo (15). Therefore, we aimed to investigate how Atoh1 affects EHCLC formation and whether Atoh1 expression defines the fate of LER cells as either ectopic, newly formed hair cells or nonsensory epithelial cells. In the present study, cultured explants were infected with several virus titers and EHCLC expression was detected in the LER at different time points. It was identified that the formation of EHCLCs was Atoh1 dependent, as no EHCLCs formed upon infection by GFP alone. Following LER infection with an appropriate titer (EGFP-atoh1) for Atoh1 expression (1.6×109 PFU/ml), EHCLC production was detected as early as 2.5 days and the number of EHCLCs increased with time. Higher Ad5-EGFP-atoh1 titers induced increased Atoh1 expression and a larger quantity of hair cell-like cells appeared at earlier time points compared with lower titers. Lower Ad5-EGFP-atoh1 titers induced less Atoh1 expression and required a greater duration for EHCLC formation. Extremely low Ad5-EGFP-atoh1 titers induced only weak Atoh1 expression and no formation of EHCLCs. Therefore, Atoh1 expression levels define the fate of LER cells as either EHCLCs or nonsensory epithelial cells, and greater Atoh1 expression decreases the time required for EHCLC formation in the LER. These data define an appropriate Ad5-EGFP-atoh1 titer range for ectopic hair cell formation and which will act as an important guideline for future studies.

Materials and methods

Cultures of postnatal rat cochleae and atoh1 gene infection

This study was approved by the Institutional Animal Care and Animal Ethics Committee of Fudan University (Xuhui, Shanghai, China). One-day-old postnatal (P1) SD rats were used for the experiments and were purchased from Slaccas Experimental Animal Company (Xuhui, Shanghai, China). The rats were sacrificed by CO2 asphyxiation. The cochlear explants culture was prepared as described previously (11,12). The final concentrations of the Ad5-EGFP-atoh1 vector were 0.1×108, 0.4×108, 0.8×108, 1.6×108 and 2.4×108 PFU/ml in serum-free DMEM/F12. The control group (Ad5-EGFP) included corresponding titers. The viruses used were as described previously (6,7,11,12).

Tissue preparation and immunofluorescence

The cochlear explants were fixed with 4% paraformaldehyde for 30 min and then treated with 0.1% Triton X-100 plus 10% donkey serum for 30 min. Following this, the explants were incubated with the following primary antibodies for 24 h at 4°C; myosin7A (1:100; Proteus Biosciences Inc., Ramona, CA, USA), myosin7A (1:200; Developmental Studies Hybridoma Bank, Iowa City, IA, USA), p27kip1 (1:100; Cell Signaling Technology, Inc., CA, USA) and Sox2 (1:300, Santa Cruz Biotechnology, Inc, Santa Cruz, CA, USA). The preparation was washed 3–5 times in PBS and then incubated with secondary antibodies for 2 h at 37°C in the dark. The secondary antibodies included donkey anti-mouse/rabbit Alexa Fluor 555 (1:1,000) and/or donkey anti-mouse/rabbit/goat (H+L) Alexa Fluor 647 (1:1,000; Molecular Probes, Invitrogen Life Technologies, Carlsbad, CA, USA). The specimens were visualized with a Zeiss LSM 510 confocal laser-scanning microscope (Carl Zeiss, Oberkochen, Germany) and only one image was captured by the microscope.

Cell counting and statistical analysis

Only cells at the LER region of the mid-basal turns were counted. Using random samples, the cells in 200 μm segments along the length of the cochlea were counted. Each group had at least five different cochlear explants and each explant was sampled at five areas. Ectopic hair cells were counted 3, 5, 7, 9 and 11 days post-infection. All the cell count was precisely performed by manually analyzing the confocal images. The values are expressed as the mean ± standard error and using a one-way ANOVA statistical test when appropriate. P<0.05 was considered to indicate a statistically significant difference.

Results

Ad5 vector transfection efficiency in the LER

The Ad5-EGFP/Ad5-EGFP-atoh1 transfection efficiency in the LER (outside of the outer hair cells) was determined by infection with different virus titers (Fig. 1). At a titer of 0.16×108 PFU/ml, only 8±2% of LER cells were GFP positive with weak green fluorescence (Fig. 1J). At a titer of 0.4×108 PFU/ml, 27±4% of LER cells were GFP positive with moderate green fluorescence (Fig. 1A and 1D and 1G). At 0.8×108 PFU/ml, 91±7% of LER cells were GFP positive with moderate-to-strong green fluorescence (Fig. 1B and 1E and 1H). At 1.6×108 PFU/ml, 94±9% of LER cells were GFP positive with strong green fluorescence (Fig. 1C and 1F and 1I). However, when 2.4×108 PFU/ml was used, the cultured explants disintegrated (Fig. 1K). Higher viral infection efficiency was observed with increasing titer, because the transfection efficiency of 0.4×108 PFU/ml was significantly higher than that of 0.16×108 PFU/ml (n=5, P<0.05) and that of 0.8×108 PFU/ml was significantly higher than that of 0.4×108 PFU/ml (n=5, P<0.05), whereas the transfection efficiency of 1.6×108 PFU/ml was similar to 0.8×108 PFU/ml (n=5, P>0.05). However, the fluorescence intensity at 1.6×108 PFU/ml was higher than at 0.8×108 PFU/ml. Therefore, it was concluded that the most effective virus titer was 1.6×108 PFU/ml.

Figure 1

Different Ad5 vector infection rates in the LER at different titers. (A and D) At 0.4×108 PFU/ml, a number of LER cells were GFP positive with moderate green fluorescence. (B and E) At 0.8×108 PFU/ml, the majority of LER cells were GFP positive with moderate to strong green fluorescence. (C and F) Following infection at 1.6×108 PFU/ml, the majority of LER cells were GFP positive with strong green fluorescence. (G–I) Magnified views of (D), (E) and (F). (J) Following infection at 0.16×108 PFU/ml, sporadic cells were GFP positive with weak green fluorescence. (K) Following infection at 2.4×108 PFU/ml, the virus damaged the cochlear explants. (L) Histogram of the Ad5-EGFP-atoh1/Ad5-EGFP infection rate (x-axis, virus titer; y-axis, number of GFP/number of DAPI). Green, GFP; blue, myosin7A; purple, DAPI. Scale: A–F, 100 μm; G–J, 50 μm. White brackets indicate the sensory epithelium. LER, lesser epithelial ridge; Ad5, human adenovirus serotype 5.

Formation of new EHCLCs at the LER is Atoh1 dependent

Following Ad-EGFP infection of the cultured explants (Fig. 2A), the LER cells presented robust EGFP fluorescence, however no myosin7A-positive cells were observed. The LER cells were unable to differentiate into hair cells. Following Ad5-EGFP-atoh1 infection, the LER was the target (Fig. 1B). Consistent with previous studies (11,14), Ad5-EGFP-atoh1 infection resulted in the induction of myosin7A-positive cells in the LER regions (Fig. 2B), suggesting that these newly formed hair cells were Atoh1 overexpression dependent. Many of the EGFP-positive cells were myosin7A negative, despite having been infected with Ad5-EGFP-atoh1. To determine whether the Atoh1 expression level or duration led to this phenomenon, different Ad5-EGFP-atoh1 titers were utilized, and the quantities and percentages of new hair cells were detected at different time points in the following study.

Figure 2

The formation of new EHCLCs at the LER is Atoh1 dependent. Cultured cochlear explants five days following Ad5-EGFP/Ad5-EGFP-atoh1 infection. (A) Ad5-EGFP (green: GFP) did not induce myosin7A (red)-positive cells in the LER. (B) Ad5-EGFP-atoh1 (green: GFP-Atoh1) induced numerous myosin7A (red)-positive cells in the LER. (C) Magnified images from (B). Scale bar: 100 μm in (A) and (B); 50 μm in (C). EHCLCs, ectopic hair-cell-like cells; LER, lesser epithelial ridge; Atoh1, Atonal homolog1; Ad5, human adenovirus serotype 5.

EHCLC formation requires a certain Atoh1 expression level

To address whether new EHCLC formation depends on Atoh1 expression, cultured explants were treated with Ad-EGFP-atoh1 at four different titers: 0.16×108, 0.4×108, 0.8×108 and 1.6×108 PFU/ml. The samples were fixed at five days following viral infection (DVI) and the numbers of EGFP-myosin7A double-positive cells and EGFP-positive cells were counted in the LER (Fig. 3). At 0.16×108 PFU/ml Ad5-EGFP-atoh1, no myosin7A-positive cells were detected, implying that low Atoh1 expression was unable to induce hair-cell-like cell formation (n=5). At 0.4×108 PFU/ml Ad5-EGFP-atoh1, there were 5±2 myosin7A-EGFP double-positive cells per 200 μm in the LER (4±3% of all EGFP-positive cells). At 0.8×108 PFU/ml Ad5-EGFP-atoh1, there were 22±4 myosin7A-EGFP double-positive cells per 200 μm in the LER (14±5% of all EGFP-positive cells). At 1.6×108 PFU/ml Ad5-EGFP-atoh1, there were 54±4 myosin7A-EGFP double-positive cells per 200 μm in LER (57±13% of all EGFP-positive cells; n=5). The number of EHCLCs in the higher virus titer groups was significantly greater compared with the lower virus titer groups (Fig. 2B). Furthermore, the LER to hair cell-like cell conversion rate was significantly enhanced in the higher than in the lower virus titer group. These data demonstrate that increasing the virus titer increased Atoh1 expression and this subsequently increased the myosin7A-positive cell number in the LER. If Atoh1 expression was too low, few LER cells converted to hair-cell-like cells. Thus, EHCLCs production was dependent on specific Atoh1 expression levels.

Figure 3

Higher Atoh1 expression levels induced the formation of more EHCLCs in the LER 5 DVI following Ad-EGFP-atoh1 infection. (A) Increasing the viral titer led to higher Atoh1 expression (GFP: green) and induced more myosin7a-positive (red) cells in the LER. (B) A bar graph illustrates the correlation between the virus titer and the number of ectopic hair cells. The cells in 200 μm segments along the length of the cochlea were counted. Scale bar: 100 μm in (A). Atoh1, Atonal homolog1; EHCLCs, ectopic hair-cell-like cells; LER, lesser epithelial ridge; Ad5, human adenovirus serotype 5; DVI, days after viral infection.

Higher Atoh1 expression reduces the duration of EHCLC formation in the LER

The number of Atoh1-induced EHCLCs increased with time. When applied to cultured explants with 0.16×108 PFU/ml Ad5-EGFP-atoh1, no myosin-positive cells were detected even at 11 DVI. At 0.4×108 PFU/ml Ad5-EGFP-atoh1, 5±2 EHCLCs per 200 μm were detected as early as 5 DVI in the LER, which increased to 12±2 at 7 DVI, 11±2 at 9 DVI and 11±1 at 11 DVI (Fig. 4A and D). At 0.8×108 PFU/ml Ad5-EGFP-atoh1, 14±1 EHCLCs per 200 μm were detected as early as 3 DVI in the LER, which increased at 22±4 on 5 DVI, 29±7 at 7 DVI, 31±2 at 9 DVI and 31±1 at 11 DVI (Fig. 4B and D). At 1.6×108 PFU/ml Ad5-EGFP-atoh1, we detected myosin7A-positive cells as early as 60 h following atoh1 infection, 31±2 EHCLCs per 200 μm were detected at 3 DVI in the LER, which increased to 54±4 on 5 DVI, 70±5 on 7 DVI, 67±6 on 9 DVI and 67±2 on 11 DVI (Fig. 4C and D). Therefore, at a low titer (0.4×108 PFU/ml) with low Atoh1 expression, EHCLC formation required a longer time (5 days). At a higher titer (1.6×108 PFU/ml) with high Atoh1 expression, however, EHCLC formation required only 2.5 days. EHCLCs increased with time but remained constant from 7–11 days in all groups (Fig. 4D). In conclusion, the Atoh1 expression level critically affected the time required for EHCLC formation.

Figure 4

Higher Atoh1 expression levels reduced the duration of EHCLCs formation in the LER. (A) Explants following Ad-EGFP-atoh1 infection at 0.4×108 PFU/ml from 3–7 DVI; (B) 0.8×108 PFU/ml from 3–7 DVI; (C) 1.6×108 PFU/ml from 3–7 DVI. (D) A bar graph demonstrates that the number of ectopic hair cells increases with time from 7–10 DVI, at different titers [x-axis: days after virus infection (virus titer); y-axis: number of EHCLCs]. Scale bar: 100 μm in (A), (B) and (C). Atoh1, Atonal homolog1; EHCLCs, ectopic hair-cell-like cells; LER, lesser epithelial ridge; Ad5, human adenovirus serotype 5; DVI, days after viral infection.

Atoh1 expression defines the fate of LER cells

The data indicated that the number of Atoh1-induced EHCLCs increased with time but this effect ceased at 7–11 days, regardless of the titer (Fig. 4D). Despite infection of cultured cochlear explants with Ad-EGFP-atoh1 at 1.6×108 PFU/ml, only ~71% of infected cells in the LER were able to transdifferentiate into hair cell-like cells. Following Ad-EGFP-atoh1 infection, a number of the infected LER cells (EGFP positive) transformed to hair-cell-like cells (myosin7A positive) with an oblong or round shape, whereas other cells remained nonsensory epithelial cells (p27kip1) with a polygonal, flat shape (Fig. 5A and B). Furthermore, many myosin7A-positive cells clustered in the LER with sox2-positive cells surrounding them, indicating that hair-cell-like cells may induce supporting cell formation (Fig. 5C and D).

Figure 5

Atoh1 expression defines the fate of LER cells. (A) Explants at 0.8×108 PFU/ml on 3 DVI. A number of GFP-positive LER cells (green) were already myosin7A positive (blue), while others were p27kip1 positive (red). (B) Magnified images from (A). (C) Explants at 0.8×108 PFU/ml at 7 DVI. A number of GFP-positive LER cells (green) were already myosin7A positive (blue), while sox2-positive cells (red) surrounded the EHCLCs. (D) Magnified images from (C). Scale bar: 50 μm in (A) and (C); 20 μm in (B) and (D). Atoh1, Atonal homolog1; EHCLCs, ectopic hair-cell-like cells; LER, lesser epithelial ridge; Ad5, human adenovirus serotype 5; DVI, days after viral infection.

Discussion

The human Ad5 vector, encoding both Atoh1 and the reporter gene EGFP, is a useful tool for new hair cell production due to its high transfection efficiency, low level of target tissue damage and ease of control (6–12,14). The viral titration in the present study indicated that appropriate titers induce optimal Atoh1 expression. At titers >2.4×108 PFU/ml, cochlear cultured explants may be severely damaged. At titers <0.16×108 PFU/ml, although weak Atoh1 expression was observed, it was not sufficient to generate ectopic hair cell formation. Our data indicate that 0.4–1.6×108 PFU/ml Ad5-EGFP-atoh1 is an efficient and safe titer range for hair-cell-like cell formation in cultured cochlear explants.

At titers of 0.16–1.6×108 PFU/ml, higher infection efficiency and expression levels were observed (Fig. 1). GFP alone did not induce EHCLCs expression, whereas Ad5-EGFP-atoh1 did induce robust EHCLCs formation. Thus, EHCLCs formation in the LER was Atoh1 expression dependent. At titers <0.1×108 PFU/ml, although a number of weakly GFP-positive cells were identified, no myosin7A-positive cells were detected, even at 11 DVI. At titers of 0.4×108 PFU/ml Ad5-EGFP-atoh1, only ~4% of atoh1-infected cells converted to hair-cell-like cells by 5 DVI in the LER. At titers of 1.6×108 PFU/ml, ~54% of atoh1-infected cells converted to hair cell-like cells. These data suggest that hair cell formation requires a certain level of Atoh1, with higher expression inducing more hair cell-like cell formation.

At 0.4–1.6×108 PFU/ml Ad5-EGFP-atoh1, EHCLC formation increased with time. At 0.4×108 PFU/ml, EHCLC formation required 5 days. However, at 1.6×108 PFU/ml, ectopic hair cell formation only required 2.5 days. Thus, greater Atoh1 expression shortens the time required for EHCLC formation. Furthermore, the number of EHCLCs increased with time but then ceased increasing at 7 DVI for all titers. Even at 1.6×108 PFU/ml, only ~71% of Ad5-EGFP-atoh1-infected cells in the LER transdifferentiated into hair cell-like cells. The fate of the non-differentiated cells may help explain this phenomenon.

The data from the present study further revealed that hair cell formation requires a certain Atoh1 expression level; if it was too low, the LER did not convert into hair cell-like cells. A number of Ad5-EGFP-atoh1-infected LER cells (EGFP positive) had already converted to hair cell-like cells (myosin7A positive) with an oblong or round shape at 3 DVI, while the other LER cells remained nonsensory epithelial cells (p27kip1 positive) with a polygonal, flat shape (Fig. 5A and B). At 3 DVI, the majority of myosin7A-positive cells exhibited a strong green fluorescence and p27kip1-positive cells appeared to have weak or no green fluorescence. However, numerous myosin7A-positive cells were observed clustered in the LER with sox2-positive cells surrounding them (Fig. 5C and D), indicating that hair cell-like cells induce supporting cell formation, which has also been previously reported (10). Therefore, the majority of Ad5-EGFP-atoh1-infected LER cells (with sufficient Atoh1 expression) converted into hair cells and induced the surrounding nonsensory epithelial cells to transform into supporting cells.

In the present study, an appropriate virus titer range for infecting cultured cochlear explants was examined, providing highly efficient infection and conversion rates but reducing the infection side effects. Atoh1 expression is critical to hair cell formation, as it defines the fate of LER cells as either hair cell-like cells or nonsensory epithelial cells. The present study provides an important guideline for future investigations to develop novel gene therapy strategies in the treatment of deafness.

Acknowledgements

This study was supported by the following: Major State Basic Research Development Program of China (973 Program) (2011CB504500, 2011CB504506) to H. L.; NSFC grant 81028003/H1305 to P. C and F. C.; Key Basic Research Project of Shanghai Committee of Science and Technology (no. 10JC1402500) to F. C.; 81200740/H1304 to J. Y.; Innovation Program of Shanghai Committee of Science and Technology (no. 11411952300) to F. C.

References

1 

Corwin JT and Cotanche DA: Regeneration of sensory hair cells after acoustic trauma. Science. 240:1772–1774. 1988. View Article : Google Scholar : PubMed/NCBI

2 

Ryals BM and Rubel EW: Hair cell regeneration after acoustic trauma in adult Coturnix quail. Science. 240:1774–1776. 1988. View Article : Google Scholar : PubMed/NCBI

3 

Bermingham NA, Hassan BA, Price SD, Vollrath MA, Ben-Arie N, Eatock RA, et al: Math1: an essential gene for the generation of inner ear hair cells. Science. 284:1837–1841. 1999. View Article : Google Scholar : PubMed/NCBI

4 

Chen P, Johnson JE, Zoghbi HY and Segil N: The role of Math1 in inner ear development: Uncoupling the establishment of the sensory primordium from hair cell fate determination. Development. 129:2495–2505. 2002.PubMed/NCBI

5 

Gubbels SP, Woessner DW, Mitchell JC, Ricci AJ and Brigande V: Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer. Nature. 455:537–541. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Han Z, Yang JM, Chi FL, Cong N, Huang YB, Gao Z, et al: Survival and fate of transplanted embryonic neural stem cells by Atoh1 gene transfer in guinea pigs cochlea. Neuroreport. 21:490–496. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Huang Y, Chi F, Han Z, Yang J, Gao W and Li Y: New ectopic vestibular hair cell-like cells induced by Math1 gene transfer in postnatal rats. Brain Res. 1276:31–38. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, et al: Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med. 11:271–276. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Kawamoto K, Ishimoto S, Minoda R, Brough DE and Raphael Y: Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci. 23:4395–4400. 2003.PubMed/NCBI

10 

Woods C, Montcouquiol M and Kelley MW: Math1 regulates development of the sensory epithelium in the mammalian cochlea. Nat Neurosci. 7:1310–1318. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Yang J, Bouvron S, Lv P, Chi F and Yamoah EN: Functional features of trans-differentiated hair cells mediated by Atoh1 reveals a primordial mechanism. J Neurosci. 32:3712–3725. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Yang J, Cong N, Han Z, Huang Y and Chi F: Ectopic hair cell-like cell induction by Math1 mainly involves direct transdifferentiation in neonatal mammalian cochlea. Neurosci Lett. 549:7–11. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Yang SM, Chen W, Guo WW, Jia S, Sun JH, Liu HZ, et al: Regeneration of stereocilia of hair cells by forced Atoh1 expression in the adult mammalian cochlea. PLoS One. 7:e463552012. View Article : Google Scholar : PubMed/NCBI

14 

Zheng JL and Gao WQ: Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears. Nat Neurosci. 3:580–586. 2000. View Article : Google Scholar : PubMed/NCBI

15 

Pan N, Jahan I, Kersigo J, Duncan JS, Kopecky B and Fritzsch B: A novel Atoh1 ‘self-terminating’ mouse model reveals the necessity of proper Atoh1 level and duration for hair cell differentiation and viability. PLoS One. 7:e303582012.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Luo WW, Yang JM, Han Z, Yuan YS, Sheng HB, Liu X and Chi FL: Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro. Mol Med Rep 10: 15-20, 2014.
APA
Luo, W., Yang, J., Han, Z., Yuan, Y., Sheng, H., Liu, X., & Chi, F. (2014). Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro. Molecular Medicine Reports, 10, 15-20. https://doi.org/10.3892/mmr.2014.2202
MLA
Luo, W., Yang, J., Han, Z., Yuan, Y., Sheng, H., Liu, X., Chi, F."Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro". Molecular Medicine Reports 10.1 (2014): 15-20.
Chicago
Luo, W., Yang, J., Han, Z., Yuan, Y., Sheng, H., Liu, X., Chi, F."Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro". Molecular Medicine Reports 10, no. 1 (2014): 15-20. https://doi.org/10.3892/mmr.2014.2202
Copy and paste a formatted citation
x
Spandidos Publications style
Luo WW, Yang JM, Han Z, Yuan YS, Sheng HB, Liu X and Chi FL: Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro. Mol Med Rep 10: 15-20, 2014.
APA
Luo, W., Yang, J., Han, Z., Yuan, Y., Sheng, H., Liu, X., & Chi, F. (2014). Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro. Molecular Medicine Reports, 10, 15-20. https://doi.org/10.3892/mmr.2014.2202
MLA
Luo, W., Yang, J., Han, Z., Yuan, Y., Sheng, H., Liu, X., Chi, F."Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro". Molecular Medicine Reports 10.1 (2014): 15-20.
Chicago
Luo, W., Yang, J., Han, Z., Yuan, Y., Sheng, H., Liu, X., Chi, F."Atoh1 expression levels define the fate of rat cochlear nonsensory epithelial cells in vitro". Molecular Medicine Reports 10, no. 1 (2014): 15-20. https://doi.org/10.3892/mmr.2014.2202
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team